BORTEZOMIB
Clinical safety rating: avoid
Contraindicated (not allowed)
Mechanism information is still being processed. Check the DailyMed link in the sidebar for the official prescribing information.
Powder for Injection 3.5 mg - Subcutaneous
Clinical note
Strong CYP3A4 inducers may decrease efficacy Peripheral neuropathy is a common and sometimes severe toxicity requiring dose adjustment.
nausea
Loading safety data…